Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Atherosclerosis
Researchers at Kumamoto University have published new data on atherosclerosis
December 15th, 2008
According to recent research from Honjo, Japan, "Context Previous trials have investigated the effects of low- dose aspirin on primary prevention of cardiovascular events, but not in patients with type 2 diabetes. To examine the efficacy of low- dose aspirin for the primary prevention of atherosclerotic events in patients with type 2 diabetes." "Setting, and Participants Multicenter, prospective, randomized, open-label, blinded, end- point trial conducted from December 2002 through April 2008 at 163 institutions throughout Japan, which enrolled 2539 patients with type 2 diabetes without a history of atherosclerotic disease and had a median follow- up of 4.37 years. ...
Source: Diabetes Week (2008-12-15)
|
